V-Wave Announces Late-Breaking Primary Results from Pivotal, Double-Blind, Randomized ...

Retrieved on: 2024-04-06 19:58:17

Tags for this article:

Heart diseases

Cardiomyopathy

Heart failure with preserved ejection fraction

Diabetic cardiomyopathy

Sacubitril/valsartan

V-Wave Inc.

United States

Click the tags to see associated articles and topics

V-Wave Announces Late-Breaking Primary Results from Pivotal, Double-Blind, Randomized .... View article details on hiswai:

Excerpt

AGOURA HILLS, Calif., April 6, 2024 /PRNewswire/ -- V-Wave Inc., a privately held medical device company, today announced primary results from the ...

Article found on: www.prnewswire.com

View Original Article